Two types of drug are used to manage benign prostatic hyperplasia (BPH). Alpha blockers, such as alfuzosin, indoramin, prazosin, tamsulosin and terazosin, relieve lower urinary tract symptoms (LUTS) ...

Old man taking a pill New study is the largest to date assessing cardiovascular risks in patients taking alpha blockers. Men who take alpha blockers (ABs) rather than 5-alpha reductase inhibitors ...

Rapaflo (silodosin), an alpha blocker marketed by Watson Pharmaceuticals, Inc., in Corona, Calif., for oral, once-daily treatment of the signs and symptoms of benign prostatic hyperplasia (BPH) has ...

Objective: The objective of this study was todirectly assess the likelihood and timing of alphablocker discontinuation in patients receivingcombination therapy with dutasteride orfinasteride plus an ...

Researchers conducted a retrospective matched cohort study to compare the risk of death among BPH patients treated with 5ARIs, as monotherapy or in combination with alpha-blockers, and those treated ...

: To evaluate the likelihood of alphaadrenergic antagonist (alpha-blocker) discontinuation in combination with dutasteride or finasteride among patients aged =65 years with enlarged prostate. Methods ...

Dublin, June 25, 2019 (GLOBE NEWSWIRE) -- The "Global Benign Prostatic Hyperplasia Market: Growth, Trends, and Forecasts (2019-2024)" report has been added to ResearchAndMarkets.com's offering. Benign ...

May 12, 2004 (San Francisco) -- The extended-release formulation of tolterodine (Detrol LA), often used to treat overactive bladder in women, is also effective in men with urinary frequency due to ...

The American Urological Association (AUA) has updated its guidelines on managing male lower urinary tract symptoms (LUTS) attributed to benign prostatic hyperplasia (BPH). The updates, the first since ...